IFIT1 抗体 (AA 1-478)
Quick Overview for IFIT1 抗体 (AA 1-478) (ABIN2607609)
抗原
See all IFIT1 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-478
- 
                                            特异性
- Human IFIT1 / ISG56
- 
                                            纯化方法
- Affinity purified
- 
                                            免疫原
- 
                        Full length human IFIT1, aa1-478 (NP_001539).
 Type of Immunogen: Recombinant protein
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, pH 7.2.
- 
                                            注意事项
- Aliquot to avoid repeated freezing and thawing.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for 1 year.
 
- 
                                            
- 
    - IFIT1 (Interferon-Induced Protein with Tetratricopeptide Repeats 1 (IFIT1))
- 
                                            别名
- IFIT1 / ISG56
- 
                                            背景
- 
                        Name/Gene ID: IFIT1
 Synonyms: IFIT1, C56, G10P1, GARG-16, IFI-56K, IFIT-1, Interferon-inducible mRNA 561, IFI-56, IFI56, IFNAI1, ISG56, RNM561, p56
- 
                                            基因ID
- 3434
- 
                                            NCBI登录号
- NP_001539
- 
                                            途径
- Hepatitis C
 抗原
- 
                    
 
                                     
                                     
                                    